226 related articles for article (PubMed ID: 34327180)
1. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Chen Y; Chen J; Zhang Y; Lin Z; Wang M; Huang L; Huang M; Tang M; Zhou X; Peng Z; Huang B; Feng ST
J Hepatocell Carcinoma; 2021; 8():795-808. PubMed ID: 34327180
[TBL] [Abstract][Full Text] [Related]
2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction of cytokeratin-19 expression for hepatocellular carcinoma using T1 mapping on gadoxetic acid-enhanced MRI combined with diffusion-weighted imaging and clinical indicators.
Zhao Y; Tan X; Chen J; Tan H; Huang H; Luo P; Liang Y; Jiang X
Front Oncol; 2022; 12():1068231. PubMed ID: 36741705
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
[TBL] [Abstract][Full Text] [Related]
5. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
6. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
[TBL] [Abstract][Full Text] [Related]
7. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
8. A radiomics nomogram for predicting cytokeratin 19-positive hepatocellular carcinoma: a two-center study.
Zhang L; Zhou H; Zhang X; Ding Z; Xu J
Front Oncol; 2023; 13():1174069. PubMed ID: 37182122
[TBL] [Abstract][Full Text] [Related]
9. A radiomics model based on magnetic resonance imaging to predict cytokeratin 7/19 expression and liver fluke infection of hepatocellular carcinoma.
Liu JQ; Wang J; Huang XL; Liang TY; Zhou X; Mo ST; Xie HX; Yang KJ; Zhu GZ; Su H; Liao XW; Long LL; Peng T
Sci Rep; 2023 Oct; 13(1):17553. PubMed ID: 37845287
[TBL] [Abstract][Full Text] [Related]
10. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
Front Oncol; 2021; 11():672126. PubMed ID: 34476208
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
12. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
[TBL] [Abstract][Full Text] [Related]
13. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma.
Hu X; Li C; Wang Q; Wu X; Chen Z; Xia F; Cai P; Zhang L; Fan Y; Ma K
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766518
[TBL] [Abstract][Full Text] [Related]
14. A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Yang L; Gu D; Wei J; Yang C; Rao S; Wang W; Chen C; Ding Y; Tian J; Zeng M
Liver Cancer; 2019 Oct; 8(5):373-386. PubMed ID: 31768346
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy.
Hu C; Song Y; Zhang J; Dai L; Tang C; Li M; Liao W; Zhou Y; Xu Y; Zhang YY; Zhou Y
Front Oncol; 2021; 11():649682. PubMed ID: 34094938
[TBL] [Abstract][Full Text] [Related]
16. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
20. Preoperative identification of cytokeratin 19 status of hepatocellular carcinoma based on diffusion kurtosis imaging.
Chen J; Liu D; Guo Y; Zhang Y; Guo Y; Jiang M; Dai Y; Yao X
Abdom Radiol (NY); 2023 Feb; 48(2):579-589. PubMed ID: 36416905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
